Journal of Adolescent Health Volume 47, Issue 3, Pages 242-248.e6 (September 2010) Amanda F. Dempsey, M.D., Ph.D., M.P.H.a, David Mendez, Ph.D.b Received 30 July 2009; accepted 8 December 2009. published online 11 February 2010. Abstract Purpose To develop a model of adolescent (HPV) human papillomavirus vaccine utilization that explored future HPV vaccination rates, with and without a […]
Abnormal Pap Test After HPV Vaccination? SaneVax Offers HPV DNA Sequencing Test to Find Out Why
PRLog
To date, there have been 283 VAERS reports of abnormal Pap tests following HPV vaccination. Gardasil and Cervarix claim to offer protection against the most common HPV viruses associated with cervical cancer. What is wrong with this picture?
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Sep 20, 2010 – Both FDA approved HPV vaccines, Gardasil and Cervarix, claim to offer protection from infections by the human papillomavirus genotypes most commonly associated with precancerous lesions and cervical cancer, HPV-16 and HPV-18. The manufacturers are also beginning to claim there is evidence of cross-protection against HPV genotypes 31 and 45. There are at least 283 young women who probably do not believe these statements.
The Vaccine Adverse Event Reporting System (VAERS) is a voluntary system. There are no requirements or legal obligations to report new medical conditions (adverse events) which occur after vaccination. Current estimates say that only 1-10% of the people who actually experience adverse events file reports.
The SaneVax team is concerned that with only 1-10% reporting, there may be as many as 28,300 people who have experienced abnormal Pap tests after HPV vaccination. This is not acceptable collateral damage.
Ultrasensitive biosensor can detect proteins, aid in cancer diagnosis
Binding can be read in real time, instead of after days or weeks of laboratory analysis, meaning the nanotube molecular imprinting technique could pave the way for biosensors capable of detecting human papillomavirus or other viruses weeks sooner than available diagnostic techniques currently allow. As opposed to searching for the HPV antibody or cell-mediated immune responses after initial infection, the nanotube sensor can track the HPV protein directly. In addition, no chemical marker is required by the label-free electrochemical detection methods.
More pushing (and more victims) of the vaccine against human papillomavirus
Pravda Ru
Miguel Jara
Rebellion
September 16, 2010
There is an ongoing campaign to expand the controversial human papillomavirus vaccination, PTO. So far, one would only vaccinate young girls, but the European Commission has extended its administration to women up to 45 years. There are some things worth noting. The first is that they used this vaccine and it was recommended for girls who had not initiated sexual intercourse. According to a study of the criteria for preparation, Gardasil, from Merck, if the female was infected there was a 44.6% chance of uterine cancer. Now it seems that they are ignoring this study.
Procedural, ethical lapses found in HPV vaccine trials in AP, Gujarat
Pharmabiz
Wednesday, September 15, 2010 08:00 IST
Joseph Alexander, New Delhi
The three-member inquiry committee set up by the Health Ministry to investigate the deaths of six children in Andhra Pradesh and Gujarat who were administered the controversial Human Papilloma Virus (HPV) vaccine is yet to submit its report even after four months against the mandated one month.
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 84
- Next Page »